These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 1811112

  • 1. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
    Mirchamsy H, Nilforoushan MA, Shafyi A, Razavi J, Ashtiani MP, Youssofi I, Sassani A, Fateh G, Nassiri S.
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M, Berger R, Just V.
    Dev Biol Stand; 1986 Sep; 65():85-8. PubMed ID: 3030863
    [Abstract] [Full Text] [Related]

  • 3. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M, Smerdel S, Dedić I, Delimar N, Rajninger-Miholic M, Juzbasić M, Manhalter T, Vlatković R, Borcić B, Mihajić Z.
    Dev Biol Stand; 1986 Sep; 65():95-100. PubMed ID: 3556780
    [Abstract] [Full Text] [Related]

  • 4. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 5. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH, Saracen CL, Peter G.
    Pediatrics; 1994 Oct 25; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [Abstract] [Full Text] [Related]

  • 6. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM, Baker L, Starr SE, Plotkin SA.
    Dev Biol Stand; 1986 Oct 25; 65():89-93. PubMed ID: 3030864
    [Abstract] [Full Text] [Related]

  • 7. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A, Glück R, Just M, Mischler R, Paroz P, Germanier R.
    Dev Biol Stand; 1986 Oct 25; 65():69-74. PubMed ID: 3556778
    [Abstract] [Full Text] [Related]

  • 8. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE, Peetermans J.
    Dev Biol Stand; 1986 Oct 25; 65():101-7. PubMed ID: 3556770
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
    Just M, Berger R, Glück R, Wegmann A.
    Dev Biol Stand; 1986 Oct 25; 65():25-7. PubMed ID: 3549399
    [Abstract] [Full Text] [Related]

  • 10. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
    Narayan KM, Moffat MA.
    Health Bull (Edinb); 1992 Jan 25; 50(1):47-53. PubMed ID: 1612895
    [Abstract] [Full Text] [Related]

  • 11. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K, Duraj V, Ljungman P, Sjölin J, Oberg G, Lönnerholm G, Fridell E, Smedmyr B, Simonsson B.
    Bone Marrow Transplant; 1992 Jun 25; 9(6):427-32. PubMed ID: 1628126
    [Abstract] [Full Text] [Related]

  • 12. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM, Saunders EF, Petric M, Gold R.
    Bone Marrow Transplant; 1996 Apr 25; 17(4):633-6. PubMed ID: 8722367
    [Abstract] [Full Text] [Related]

  • 13. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B, Smerdel S, Abu Eldan J, Kolić J, Ferdebar M, Kordić D, Mohacek N.
    Lijec Vjesn; 1989 Apr 25; 111(4-5):131-4. PubMed ID: 2770398
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of mumps antibodies after measles-mumps-rubella (MMR) vaccines.
    Ozaki K, Kuno-Sakai H, Kimura M.
    Tokai J Exp Clin Med; 1987 Dec 25; 12(5-6):305-11. PubMed ID: 3508655
    [Abstract] [Full Text] [Related]

  • 15. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T, Baba K, Tsuda N, Yabuuchi H, Yamanishi K, Takahashi M.
    Biken J; 1986 Dec 25; 29(3-4):63-71. PubMed ID: 3304276
    [Abstract] [Full Text] [Related]

  • 16. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE, Markowitz LE, Heath J, Redd SC, Coleman S, Bellini WJ, Sievert A.
    JAMA; 1996 Mar 06; 275(9):704-7. PubMed ID: 8594268
    [Abstract] [Full Text] [Related]

  • 17. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A, Gerike E.
    Vaccine; 2000 Jan 31; 18(14):1382-92. PubMed ID: 10618536
    [Abstract] [Full Text] [Related]

  • 18. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.
    Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835
    [Abstract] [Full Text] [Related]

  • 19. Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age.
    Singh R, John TJ, Cherian T, Raghupathy P.
    Indian J Med Res; 1994 Oct 28; 100():155-9. PubMed ID: 7851964
    [Abstract] [Full Text] [Related]

  • 20. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
    Tidjani O, Grunitzky B, Guérin N, Lévy-Bruhl D, Lecam N, Xuereff C, Tatagan K.
    Bull Soc Pathol Exot; 1991 Oct 28; 84(5 Pt 5):873-84. PubMed ID: 1819435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.